Trademark applications and grants for Euclises Pharmaceuticals Inc. Euclises Pharmaceuticals Inc has 2 trademark applications. The latest application filed is for "EUCLICOXIB"
Patent Application | Date |
---|---|
COMBINATION OF A CHROMENE COMPOUND AND A SECOND ACTIVE AGENT 20220265602 - 17/744185 TALLEY; John J. ;   et al. | 2022-08-25 |
COMBINATION OF A CHROMENE COMPOUND AND A SECOND ACTIVE AGENT 20170196835 - 15/401777 TALLEY; John J. ;   et al. | 2017-07-13 |
NO-RELEASING NITROOXY-CHROMENE CONJUGATES 20160340330 - 15/111767 TALLEY; JOHN J. ;   et al. | 2016-11-24 |
NO-RELEASING GUANIDINE-CHROMENE CONJUGATES 20150197500 - 14/596975 Talley; John J. ;   et al. | 2015-07-16 |
NO-RELEASING NITROOXY-METHYLENE-LINKED-COXIB CONJUGATES 20150197494 - 14/597003 Talley; John J. ;   et al. | 2015-07-16 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "EUCLICOXIB" 86439701 |
EUCLICOXIB 2014-10-30 |
![]() "EUCLISES" 5438543 86439696 |
EUCLISES 2014-10-30 |
NCAGE Code | 6LG03 | EUCLISES PHARMACEUTICALS INC |
CAGE Code | 6LG03 | EUCLISES PHARMACEUTICALS INC |
S.A.M. Registration | 6LG03 [969894281] | EUCLISES PHARMACEUTICALS INC |
DUNS | 969894281 | EUCLISES PHARMACEUTICALS INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.